Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis

Key Points

• Serum miRNA-155 and TREM2 correlate with neuroinflammation in multiple sclerosis.
• Significant changes in biomarkers were observed, indicating disease activity.
• Assessment using serum samples from multiple sclerosis patients highlights non-invasive markers.
• Findings support the use of miRNA-155 and TREM2 for therapeutic monitoring in clinical settings.